Validations: Biologics, ATMP & Viral Safety Validation
Exception Handling in COI/COC: Investigations That Work Exception Handling in Chain-of-Identity/Chain-of-Custody: Investigations That Work In a biopharmaceutical environment, the integrity of the Chain-of-Identity (COI) and Chain-of-Custody (COC) is paramount for ensuring that a product’s lineage and quality are traceable throughout its lifecycle. This article provides a step-by-step tutorial on handling exceptions in COI/COC through effective investigations essential for compliance with…
Automation Opportunities in Bioassays Understanding the Landscape of Bioassays in Biologics Validation The validation of bioassays is fundamental in ensuring the safety and efficacy of biologics, including advanced therapy medicinal products (ATMPs). The complexity of these products necessitates robust methodologies to monitor and confirm their quality as defined by regulatory standards such as FDA guidelines and EMA requirements. This article…
Training Programs for Bioassay Analysts: A Comprehensive Guide In today’s highly regulated pharmaceutical landscape, ensuring the integrity and quality of biological products is paramount. Training programs for bioassay analysts focus on robust methodologies, strict adherence to regulatory standards, and comprehensive understanding of critical biological processes. This guide outlines a step-by-step approach for designing effective training programs that cater specifically to…
Governance for Complex CQAs Across Networks Governance for Complex CQAs Across Networks 1. Introduction to CQAs and Their Importance in Biologics Validation In the rapidly evolving landscape of biopharmaceuticals, effective governance of Complex Quality Attributes (CQAs) is essential for ensuring product quality and regulatory compliance. This is particularly crucial for Advanced Therapy Medicinal Products (ATMPs), where potency and identity are…
Chain-of-Identity vs Chain-of-Custody: What Each Proves Chain-of-Identity vs Chain-of-Custody: What Each Proves The concepts of Chain-of-Identity (COI) and Chain-of-Custody (COC) are increasingly critical in the pharmaceutical industry, especially for biologics, Advanced Therapy Medicinal Products (ATMPs), and viral safety validation. Understanding these principles is essential for ensuring that products meet regulatory standards set out by entities such as the US FDA,…
Assay Storyboards for HA Queries: A Comprehensive Guide for Pharmaceutical Validation The validation of assays in the pharmaceutical industry, especially in the context of biologics and advanced therapy medicinal products (ATMPs), is a critical component of ensuring product quality and compliance with regulatory standards. This article outlines a step-by-step tutorial on developing assay storyboards tailored to Health Authority (HA) queries….
Common Potency/Identity Pitfalls—and Fixes Common Potency/Identity Pitfalls—and Fixes Understanding Potency and Identity in Biologics Validation The validation of potency and identity in biologics, particularly Advanced Therapy Medicinal Products (ATMPs), is pivotal for ensuring the safety and efficacy of pharmaceutical products. Potency refers to the biological activity of a drug in measured doses, while identity confirms that the product is what…
Templates: Bioassay Validation Protocols Templates: Bioassay Validation Protocols This tutorial serves as an intricate guide to bioassay validation protocols within the biopharmaceutical sector. With a specific emphasis on viral clearance validation, spiking studies, and compliance with regulatory frameworks such as FDA, EMA, and MHRA, the following sections break down the necessary templates and methodologies required to ensure that your validation…
Critical Raw Materials for Assays: Oversight Rules Critical Raw Materials for Assays: Oversight Rules In the field of pharmaceutical and biotechnology development, the significance of raw materials, particularly for assays employed in biologics and advanced therapy medicinal products (ATMPs), cannot be understated. Ensuring the quality, safety, and efficacy of these materials through stringent validation processes is essential for compliance with…
Method Transfers for Complex Assays: Planning & Evidence Method Transfers for Complex Assays: Planning & Evidence In the domain of pharmaceutical validation, method transfers for complex assays play a crucial role in ensuring product safety and efficacy. This guide serves as a comprehensive resource for professionals overseeing the validation processes, focusing on the key aspects of viral clearance validation, spiking…